Microbiology

Research output

Research output per year 1970 2016 2018 2020 2021 2022 2023

• 130397 Citations
• 171 h-index
• 1504 Article
• 131 Review article
• 85 Comment/debate
• 34 Chapter
• 71 More
  • 32 Letter
  • 20 Short survey
  • 17 Editorial
  • 1 Book
  • 1 Foreword/postscript

Research output per year

Research output per year

Search results

• 2022

  Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface

  Zhu, X., Han, J., Sun, W., Puente-Massaguer, E., Yu, W., Palese, P., Krammer, F., Ward, A. B. & Wilson, I. A., 24 May 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 21, e2200821119.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemagglutinins 100%
  • Human Influenza 82%
  • Antibodies 49%
  • Head 28%
  • Vaccines 19%
  1 Scopus citations

• Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV

  Motsoeneng, B. M., Dhar, N., Nunes, M. C., Krammer, F., Madhi, S. A., Moore, P. L. & Richardson, S. I., 19 Apr 2022, In: Frontiers in Immunology. 13, 873191.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemagglutinins 100%
  • Human Influenza 82%
  • Vaccination 71%
  • HIV 61%
  • Antibodies 39%

• Innovative vaccine approaches—a Keystone Symposia report

  Cable, J., Rappuoli, R., Klemm, E. J., Kang, G., Mutreja, A., Wright, G. J., Pizza, M., Castro, S. A., Hoffmann, J. P., Alter, G., Carfi, A., Pollard, A. J., Krammer, F., Gupta, R. K., Wagner, C. E., Machado, V., Modjarrad, K., Corey, L., B. Gilbert, P., Dougan, G., & 14 othersLurie, N., Bjorkman, P. J., Chiu, C., Nemes, E., Gordon, S. B., Steer, A. C., Rudel, T., Blish, C. A., Sandberg, J. T., Brennan, K., Klugman, K. P., Stuart, L. M., Madhi, S. A. & Karp, C. L., May 2022, In: Annals of the New York Academy of Sciences. 1511, 1, p. 59-86 28 p.

  Research output: Contribution to journal › Article › peer-review

  • Keystone 100%
  • Vaccine 84%
  • Vaccines 57%
  • Industry 55%
  • Global Health 9%
  3 Scopus citations

• Interaction between chicken TRIM25 and MDA5 and their role in mediated antiviral activity against IBDV infection

  Diaz-Beneitez, E., Cubas-Gaona, L. L., Candelas-Rivera, O., Benito-Zafra, A., Sánchez-Aparicio, M. T., Miorin, L., Rodríguez, J. F., García-Sastre, A. & Rodríguez, D., 28 Nov 2022, In: Frontiers in Microbiology. 13, 1068328.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Infectious bursal disease virus 100%
  • Chickens 61%
  • Antiviral Agents 54%
  • Virus Diseases 46%
  • Ubiquitin-Protein Ligases 31%
  1 Scopus citations

• Introduction and Differential Diagnosis of Monkeypox in Argentina, 2022

  Lewis, A., Josiowicz, A., Riade, S. M. H., Tous, M., Palacios, G. & Cisterna, D. M., Oct 2022, In: Emerging Infectious Diseases. 28, 10, p. 2123-2125 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Monkeypox 100%
  • Monkeypox virus 99%
  • Hand-Foot Syndrome 84%
  • Argentina 71%
  • Enterovirus 67%
  7 Scopus citations

• ISG15 deficiency restricts HIV-1 infection

  Jurczyszak, D., Manganaro, L., Buta, S., Gruber, C., Martin-Fernandez, M., Taft, J., Patel, R., Cipolla, M., Alshammary, H., Mulder, L. C. F., Sachidanandam, R., Bogunovic, D. & Simon, V., Mar 2022, In: PLoS Pathogens. 18, 3, e1010405.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human immunodeficiency virus 1 100%
  • interferons 92%
  • Interferons 74%
  • HIV Infections 72%
  • HIV-1 70%
  3 Scopus citations

• Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

  Cable, J., Fauci, A., Dowling, W. E., Günther, S., Bente, D. A., Yadav, P. D., Madoff, L. C., Wang, L. F., Arora, R. K., Van Kerkhove, M., Chu, M. C., Jaenisch, T., Epstein, J. H., Frost, S. D. W., Bausch, D. G., Hensley, L. E., Bergeron, É., Sitaras, I., Gunn, M. D., Geisbert, T. W., & 14 othersMuñoz-Fontela, C., Krammer, F., de Wit, E., Nordenfelt, P., Saphire, E. O., Gilbert, S. C., Corbett, K. S., Branco, L. M., Baize, S., van Doremalen, N., Krieger, M. A., Clemens, S. A. C., Hesselink, R. & Hartman, D., Dec 2022, In: Annals of the New York Academy of Sciences. 1518, 1, p. 209-225 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Keystone 100%
  • Zoonoses 81%
  • Pandemics 80%
  • Industry 55%
  • Virus 45%

• Limited extent and consequences of pancreatic SARS-CoV-2 infection

  van der Heide, V., Jangra, S., Cohen, P., Rathnasinghe, R., Aslam, S., Aydillo, T., Geanon, D., Handler, D., Kelley, G., Lee, B., Rahman, A., Dawson, T., Qi, J., D'Souza, D., Kim-Schulze, S., Panzer, J. K., Caicedo, A., Kusmartseva, I., Posgai, A. L., Atkinson, M. A., & 5 othersAlbrecht, R. A., García-Sastre, A., Rosenberg, B. R., Schotsaert, M. & Homann, D., 15 Mar 2022, In: Cell Reports. 38, 11, 110508.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus Infections 100%
  • Severe Acute Respiratory Syndrome 90%
  • Coronavirus 87%
  • Risk Assessment 84%
  • Infections 19%
  21 Scopus citations

• Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination

  Pang, A. P. S., Higgins-Chen, A. T., Comite, F., Raica, I., Arboleda, C., Went, H., Mendez, T., Schotsaert, M., Dwaraka, V., Smith, R., Levine, M. E., Ndhlovu, L. C. & Corley, M. J., 3 Jun 2022, In: Frontiers in Genetics. 13, 819749.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • DNA Methylation 100%
  • Epigenomics 88%
  • Longitudinal Studies 84%
  • Vaccination 81%
  • Messenger RNA 57%
  4 Scopus citations

• Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina

  Chahla, R. E., Tomas-Grau, R. H., Cazorla, S. I., Ploper, D., Vera Pingitore, E., López, M. A., Aznar, P., Alcorta, M. E., Vélez, E. M. D. M., Stagnetto, A., Ávila, C. L., Maldonado-Galdeano, C., Socias, S. B., Heinze, D., Navarro, S. A., Llapur, C. J., Costa, D., Flores, I., Edelstein, A., Kowdle, S., & 7 othersPerandones, C., Lee, B., Apfelbaum, G., Mostoslavsky, R., Mostoslavsky, G., Perdigón, G. & Chehín, R. N., Feb 2022, In: The Lancet Regional Health - Americas. 6, 100123.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Argentina 100%
  • vaccination 92%
  • Vaccination 66%
  • Cohort Studies 56%
  • Prospective Studies 52%
  23 Scopus citations

• Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants

  Hernandez-Davies, J. E., Dollinger, E. P., Pone, E. J., Felgner, J., Liang, L., Strohmeier, S., Jan, S., Albin, T. J., Jain, A., Nakajima, R., Jasinskas, A., Krammer, F., Esser-Kahn, A., Felgner, P. L., Nie, Q. & Davies, D. H., Dec 2022, In: Scientific Reports. 12, 1, 9198.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemagglutinins 100%
  • Human Influenza 82%
  • Immunoglobulin G 67%
  • Vaccines 67%
  • Influenza Vaccines 50%
  4 Scopus citations

• Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene

  Edwards, M. R., Vogel, O. A., Mori, H., Davey, R. A. & Basler, C. F., Sep 2022, In: mBio. 13, 5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Marburgvirus 100%
  • Glycoproteins 53%
  • Genes 25%
  • Filoviridae 24%
  • Marburg virus VP30 protein 20%

• Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization

  Norris, M. J., Husby, M. L., Kiosses, W. B., Yin, J., Saxena, R., Rennick, L. J., Heiner, A., Harkins, S. S., Pokhrel, R., Schendel, S. L., Hastie, K. M., Landeras-Bueno, S., Salie, Z. L., Lee, B., Chapagain, P. P., Maisner, A., Paul Duprex, W., Stahelin, R. V. & Saphire, E. O., Jul 2022, In: Science advances. 8, 29, eabn1440.

  Research output: Contribution to journal › Article › peer-review

  • Nipah Virus 100%
  • Virus Assembly 82%
  • Measles virus 80%
  • Polymerization 64%
  • Virion 60%
  2 Scopus citations

• MERS-CoV ORF4b employs an unusual binding mechanism to target IMPα and block innate immunity

  Munasinghe, T. S., Edwards, M. R., Tsimbalyuk, S., Vogel, O. A., Smith, K. M., Stewart, M., Foster, J. K., Bosence, L. A., Aragão, D., Roby, J. A., Basler, C. F. & Forwood, J. K., Dec 2022, In: Nature Communications. 13, 1, 1604.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • IMP 100%
  • Inosine Monophosphate 83%
  • Coronavirus 79%
  • immunity 73%
  • Innate Immunity 58%
  3 Scopus citations

• Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

  Figueiredo, J. C., Hirsch, F. R., Kushi, L. H., Nembhard, W. N., Crawford, J. M., Mantis, N., Finster, L., Merin, N. M., Merchant, A., Reckamp, K. L., Melmed, G. Y., Braun, J., Mcgovern, D., Parekh, S., Corley, D. A., Zohoori, N., Amick, B. C., Du, R., Gregersen, P. K., Diamond, B., & 77 othersTaioli, E., Sariol, C., Espino, A., Weiskopf, D., Gifoni, A., Brien, J., Hanege, W., Lipsitch, M., Zidar, D. A., Scheck Mcalearney, A., Wajnberg, A., Labaer, J., Yvonne Lewis, E., Binder, R. A., Moormann, A. M., Forconi, C., Forrester, S., Batista, J., Schieffelin, J., Kim, D., Biancon, G., Vanoudenhove, J., Halene, S., Fan, R., Barouch, D. H., Alter, G., Pinninti, S., Boppana, S. B., Pati, S. K., Latting, M., Karaba, A. H., Roback, J., Sekaly, R., Neish, A., Brincks, A. M., Granger, D. A., Karger, A. B., Thyagarajan, B., Thomas, S. N., Klein, S. L., Cox, A. L., Lucas, T., Furr-Holden, D., Key, K., Jones, N., Wrammerr, J., Suthar, M., Yu Wong, S., Bowman, N. M., Simon, V., Richardson, L. D., Mcbride, R., Krammer, F., Rana, M., Kennedy, J., Boehme, K., Forrest, C., Granger, S. W., Heaney, C. D., Knight Lapinski, M., Wallet, S., Baric, R. S., Schifanella, L., Lopez, M., Fernandez, S., Kenah, E., Panchal, A. R., Britt, W. J., Sanz, I., Dhodapkar, M., Ahmed, R., Bartelt, L. A., Markmann, A. J., Lin, J. T., Hagan, R. S., Wolfgang, M. C. & Skarbinski, J., 1 Jun 2022, In: Open Forum Infectious Diseases. 9, 6, ofac171.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Organizations 66%
  • Epidemiologic Studies 66%
  • Direction compound 57%
  • Cohort Studies 54%
  2 Scopus citations

• Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models

  Choudhary, S., Kanevsky, I., Yildiz, S., Sellers, R. S., Swanson, K. A., Franks, T., Rathnasinghe, R., Munoz-Moreno, R., Jangra, S., Gonzalez, O., Meade, P., Coskran, T., Qian, J., Lanz, T. A., Johnson, J. G., Tierney, C. A., Smith, J. D., Tompkins, K., Illenberger, A., Corts, P., & 13 othersCiolino, T., Dormitzer, P. R., Dick, E. J., Shivanna, V., Hall-Ursone, S., Cole, J., Kaushal, D., Fontenot, J. A., Martinez-Romero, C., McMahon, M., Krammer, F., Schotsaert, M. & García-Sastre, A., Apr 2022, In: Toxicologic Pathology. 50, 3, p. 280-293 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytopathic 100%
  • Severe Acute Respiratory Syndrome 82%
  • Coronavirus 80%
  • Mesocricetus 77%
  • Macaca mulatta 67%
  9 Scopus citations

• Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects

  On behalf of Grupo Viruela del Simio Madrid CNM/ISCIII/HCSC/Sandoval, Oct 2022, In: Journal of Infection. 85, 4, p. 412-417 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Monkeypox 100%
  • Orthopoxvirus 90%
  • Spain 57%
  • Disease Outbreaks 51%
  • Fever 44%
  71 Scopus citations

• Monoclonal antibodies targeting the influenza virus N6 neuraminidase

  Strohmeier, S., Amanat, F., Carreño, J. M. & Krammer, F., 27 Jul 2022, In: Frontiers in Immunology. 13, 944907.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuraminidase 100%
  • Orthomyxoviridae 89%
  • Monoclonal Antibodies 64%
  • Viruses 49%
  • Hemagglutinins 32%

• mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

  Kaplonek, P., Cizmeci, D., Fischinger, S., Collier, A. R., Suscovich, T., Linde, C., Broge, T., Mann, C., Amanat, F., Dayal, D., Rhee, J., De St. Aubin, M., Nilles, E. J., Musk, E. R., Menon, A. S., Saphire, E. O., Krammer, F., Lauffenburger, D. A., Barouch, D. H. & Alter, G., 18 May 2022, In: Science Translational Medicine. 14, 645, eabm2311.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus 100%
  • Vaccines 59%
  • Messenger RNA 45%
  • Antibodies 44%
  • Humoral Immunity 16%
  44 Scopus citations

• mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

  Carreño, J. M., Singh, G., Tcheou, J., Srivastava, K., Gleason, C., Muramatsu, H., Desai, P., Aberg, J. A., Miller, R. L., study group, PARIS., Pardi, N., Simon, V. & Krammer, F., 6 Oct 2022, In: Vaccine. 40, 42, p. 6114-6124 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Polyethylene Glycols 100%
  • polyethylene glycol 86%
  • messenger RNA 86%
  • vaccines 77%
  • Vaccines 67%
  11 Scopus citations

• mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

  Kaplonek, P., Fischinger, S., Cizmeci, D., Bartsch, Y. C., Kang, J., Burke, J. S., Shin, S. A., Dayal, D., Martin, P., Mann, C., Amanat, F., Julg, B., Nilles, E. J., Musk, E. R., Menon, A. S., Krammer, F., Saphire, E. O., Andrea Carfi, C. & Alter, G., 8 Feb 2022, In: Immunity. 55, 2, p. 355-365.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Vaccines 50%
  • Messenger RNA 38%
  • Antibodies 37%
  • Fc Receptors 23%
  34 Scopus citations

• Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model

  Tan, J., Chromikova, V., O'Dell, G., Sordillo, E. M., Simon, V., van Bakel, H., Krammer, F. & McMahon, M., Sep 2022, In: mSphere. 7, 5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Influenza B virus 100%
  • Guinea Pigs 64%
  • Monoclonal Antibodies 53%
  • Viruses 49%
  • Intranasal Administration 46%

• Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine

  Nogales, A., Steel, J., Liu, W. C., Lowen, A. C., Rodriguez, L., Chiem, K., Cox, A., García-Sastre, A., Albrecht, R. A., Dewhurst, S. & Martínez-Sobrido, L., Jun 2022, In: Microbiology spectrum. 10, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • influenza 100%
  • vaccine 99%
  • Influenza Vaccines 91%
  • Influenza A virus 88%
  • mutation 79%
  1 Scopus citations

• Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission

  Escalera, A., Gonzalez-Reiche, A. S., Aslam, S., Mena, I., Laporte, M., Pearl, R. L., Fossati, A., Rathnasinghe, R., Alshammary, H., van de Guchte, A., Farrugia, K., Qin, Y., Bouhaddou, M., Kehrer, T., Zuliani-Alvarez, L., Meekins, D. A., Balaraman, V., McDowell, C., Richt, J. A., Bajic, G., & 9 othersSordillo, E. M., Dejosez, M., Zwaka, T. P., Krogan, N. J., Simon, V., Albrecht, R. A., van Bakel, H., García-Sastre, A. & Aydillo, T., 9 Mar 2022, In: Cell Host and Microbe. 30, 3, p. 373-387.e7

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • virus transmission 80%
  • hamsters 63%
  • mutation 46%
  • Cricetinae 45%
  62 Scopus citations

• Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice

  Hioe, C. E., Li, G., Liu, X., Tsahouridis, O., He, X., Funaki, M., Klingler, J., Tang, A. F., Feyznezhad, R., Heindel, D. W., Wang, X. H., Spencer, D. A., Hu, G., Satija, N., Prévost, J., Finzi, A., Hessell, A. J., Wang, S., Lu, S., Chen, B. K., & 4 othersZolla-Pazner, S., Upadhyay, C., Alvarez, R. & Su, L., Jan 2022, In: PLoS Pathogens. 18, 1, e1010183.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human immunodeficiency virus 1 100%
  • viral load 94%
  • HIV-1 70%
  • Virus Diseases 59%
  • antibodies 53%
  4 Scopus citations

• Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies

  Roubidoux, E. K., Sano, K., McMahon, M., Carreño, J. M., Capuano, C., Jiang, K., Simon, V., van Bakel, H., Wilson, P. & Krammer, F., May 2022, In: Journal of Virology. 96, 9

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Orthomyxoviridae 100%
  • sialidase 97%
  • Neuraminidase 95%
  • epitopes 81%
  • monoclonal antibodies 75%
  3 Scopus citations

• Nuclear speckle integrity and function require TAO2 kinase

  Gao, S., Esparza, M., Dehghan, I., Aksenova, V., Zhang, K., Batten, K., Ferretti, M. B., Begg, B. E., Cagatay, T., Shay, J. W., Garcıa-Sastre, A., Goldsmith, E. J., Chen, Z. J., Dasso, M., Lynch, K. W., Cobb, M. H. & Fontoura, B. M. A., 21 Jun 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 25, e2206046119.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Phosphotransferases 100%
  • Messenger RNA 73%
  • RNA Splicing 69%
  • Cell Nucleus Active Transport 60%
  • Viral Proteins 54%

• Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses

  Kainth, M. K., Fishbein, J. S., Aydillo, T., Escalera, A., Odusanya, R., Grammatikopoulos, K., Scotto, T., Sethna, C. B., García-Sastre, A. & Deutschman, C. S., Jan 2022, In: Viruses. 14, 1, 124.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Influenza Vaccines 100%
  • Obesity 61%
  • Child 38%
  • Vaccination 21%
  • Human Influenza 18%
  5 Scopus citations

• PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2

  PARIS/SPARTA Study Group, Jun 2022, In: mSphere. 7, 3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Severe Acute Respiratory Syndrome 87%
  • Coronavirus 85%
  • Immunity 55%
  • Vaccination 27%
  4 Scopus citations

• Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2

  Williams, E., Colson, J., Valiathan, R., Carreño, J. M., Krammer, F., Hoffer, M., Pallikkuth, S., Pahwa, S. & Andrews, D., 29 Sep 2022, In: Vaccine. 40, 41, p. 5868-5872 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe acute respiratory syndrome coronavirus 100%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 72%
  • neutralizing antibodies 67%
  • Neutralizing Antibodies 58%
  1 Scopus citations

• Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

  the IMPACC study group members, Sep 2022, In: eBioMedicine. 83, 104208.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunophenotyping 100%
  • Coronavirus 99%
  • Lymphopenia 77%
  • Mechanical Ventilation 74%
  • Cohort Studies 54%
  10 Scopus citations

• Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

  Varona, J. F., Landete, P., Lopez-Martin, J. A., Estrada, V., Paredes, R., Guisado-Vasco, P., de Orueta, L. F., Torralba, M., Fortun, J., Vates, R., Barberan, J., Clotet, B., Ancochea, J., Carnevali, D., Cabello, N., Porras, L., Gijon, P., Monereo, A., Abad, D., Zuñiga, S., & 31 othersSola, I., Rodon, J., Vergara-Alert, J., Izquierdo-Useros, N., Fudio, S., Pontes, M. J., de Rivas, B., de Velasco, P. G., Nieto, A., Gomez, J., Aviles, P., Lubomirov, R., Belgrano, A., Sopesen, B., White, K. M., Rosales, R., Yildiz, S., Reuschl, A. K., Thorne, L. G., Jolly, C., Towers, G. J., Zuliani-Alvarez, L., Bouhaddou, M., Obernier, K., McGovern, B. L., Rodriguez, M. L., Enjuanes, L., Fernandez-Sousa, J. M., Krogan, N. J., Jimeno, J. M. & Garcia-Sastre, A., Apr 2022, In: Life Science Alliance. 5, 4, 202101200.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Plitidepsin 100%
  • plitidepsin 86%
  • severe acute respiratory syndrome 70%
  • SARS Virus 28%
  • nausea 23%
  19 Scopus citations

• Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations

  Peña, N., Zhang, W., Watkins, C., Halucha, M., Alshammary, H., Hernandez, M. M., Liu, W. C., Albrecht, R. A., Garcia-Sastre, A., Simon, V., Katanski, C. & Pan, T., 3 Feb 2022, In: Frontiers in Cell and Developmental Biology. 10, 768356.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Product Packaging 78%
  • Viral RNA 74%
  • RNA 47%
  • Transfer RNA 37%
  1 Scopus citations

• Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

  Ying, B., Whitener, B., VanBlargan, L. A., Hassan, A. O., Shrihari, S., Liang, C. Y., Karl, C. E., Mackin, S., Chen, R. E., Kafai, N. M., Wilks, S. H., Smith, D. J., Carreño, J. M., Singh, G., Krammer, F., Carfi, A., Elbashir, S. M., Edwards, D. K., Thackray, L. B. & Diamond, M. S., 2 Feb 2022, In: Science Translational Medicine. 14, 630, eabm3302.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Vaccines 58%
  • Messenger RNA 44%
  • K-18 conjugate 42%
  23 Scopus citations

• Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza

  Günther, S. C., Martínez-Romero, C., Borau, M. S., Pham, C. T. N., García-Sastre, A. & Stertz, S., Aug 2022, In: Microbiology spectrum. 10, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cathepsin W 100%
  • cathepsins 62%
  • influenza 58%
  • proteomics 57%
  • virus 45%
  2 Scopus citations

• Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples

  Escalera, A., García-Sastre, A. & Aydillo, T., 16 Sep 2022, In: STAR Protocols. 3, 3, 101502.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Cleavage 46%
  • Protein 28%
  • Proteins 24%
  • Mutation 19%

• Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model

  Liu, K. T., Gong, Y. N., Huang, C. G., Huang, P. N., Yu, K. Y., Lee, H. C., Lee, S. C., Chiang, H. J., Kung, Y. A., Lin, Y. T., Hsiao, M. J., Huang, P. W., Huang, S. Y., Wu, H. T., Wu, C. C., Kuo, R. L., Chen, K. F., Hung, C. T., Oguntuyo, K. Y., Stevens, C. S., & 5 othersKowdle, S., Chiu, H. P., Lee, B., Chen, G. W. & Shih, S. R., Feb 2022, In: mSphere. 7, 1, e00883-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neutralization Tests 100%
  • Neutralizing Antibodies 95%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 48%
  • Viral Proteins 40%
  7 Scopus citations

• Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

  Schwarz, M., Torre, D., Lozano-Ojalvo, D., Tan, A. T., Tabaglio, T., Mzoughi, S., Sanchez-Tarjuelo, R., Le Bert, N., Lim, J. M. E., Hatem, S., Tuballes, K., Camara, C., Lopez-Granados, E., Paz-Artal, E., Correa-Rocha, R., Ortiz, A., Lopez-Hoyos, M., Portoles, J., Cervera, I., Gonzalez-Perez, M., & 34 othersBodega-Mayor, I., Conde, P., Oteo-Iglesias, J., Borobia, A. M., Carcas, A. J., Frías, J., Belda-Iniesta, C., Ho, J. S. Y., Nunez, K., Hekmaty, S., Mohammed, K., Marsiglia, W. M., Carreño, J. M., Dar, A. C., Berin, C., Nicoletti, G., Della Noce, I., Colombo, L., Lapucci, C., Santoro, G., Ferrari, M., Nie, K., Patel, M., Barcessat, V., Gnjatic, S., Harris, J., Sebra, R., Merad, M., Krammer, F., Kim-schulze, S., Marazzi, I., Bertoletti, A., Ochando, J. & Guccione, E., Nov 2022, In: Nature Biotechnology. 40, 11, p. 1680-1689 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • T-cells 100%
  • SARS Virus 99%
  • Messenger RNA 88%
  • Assays 78%
  • Cellular Immunity 65%
  11 Scopus citations

• Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display

  Tanaka, S., Olson, C. A., Barnes, C. O., Higashide, W., Gonzalez, M., Taft, J., Richardson, A., Martin-Fernandez, M., Bogunovic, D., Gnanapragasam, P. N. P., Bjorkman, P. J., Spilman, P., Niazi, K., Rabizadeh, S. & Soon-Shiong, P., 8 Feb 2022, In: Cell Reports. 38, 6, 110348.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Epitope 79%
  • Neutralizing Antibodies 77%
  • angiotensin converting enzyme 2 57%
  5 Scopus citations

• Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial

  Folschweiller, N., Vanden Abeele, C., Chu, L., Van Damme, P., García-Sastre, A., Krammer, F., Nachbagauer, R., Palese, P., Solórzano, A., Bi, D., David, M. P., Friel, D., Innis, B. L., Koch, J., Mallett, C. P., Rouxel, R. N., Salaun, B., Vantomme, V., Verheust, C. & Struyf, F., Jul 2022, In: The Lancet Infectious Diseases. 22, 7, p. 1062-1075 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Influenza Vaccines 100%
  • Hemagglutinins 98%
  • Virion 83%
  • Human Influenza 80%
  • Vaccines 65%
  5 Scopus citations

• Recall of B cell memory depends on relative locations of prime and boost immunization

  Kuraoka, M., Yeh, C. H., Bajic, G., Kotaki, R., Song, S., Windsor, I., Harrison, S. C. & Kelsoe, G., May 2022, In: Science immunology. 7, 71, eabn5311.

  Research output: Contribution to journal › Article › peer-review

  • Germinal Center 100%
  • Immunization 77%
  • B-Lymphocytes 70%
  • B-Cell Antigen Receptors 26%
  • Heterophile Antigens 10%
  8 Scopus citations

• Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA

  Yoh, S. M., Mamede, J. I., Lau, D., Ahn, N., Sánchez-Aparicio, M. T., Temple, J., Tuckwell, A., Fuchs, N. V., Cianci, G. C., Riva, L., Curry, H., Yin, X., Gambut, S., Simons, L. M., Hultquist, J. F., König, R., Xiong, Y., García-Sastre, A., Böcking, T., Hope, T. J., & 1 othersChanda, S. K., 4 Aug 2022, In: Molecular Cell. 82, 15, p. 2871-2884.e6

  Research output: Contribution to journal › Article › peer-review

  • GMP synthase (glutamine-hydrolyzing) 100%
  • Capsid 90%
  • cyclic guanosine monophosphate-adenosine monophosphate 89%
  • Licensure 85%
  • Pathogen-Associated Molecular Pattern Molecules 79%
  8 Scopus citations

• Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production

  Bracci, N., de la Fuente, C., Saleem, S., Pinkham, C., Narayanan, A., García-Sastre, A., Balaraman, V., Richt, J. A., Wilson, W. & Kehn-Hall, K., Feb 2022, In: Virology. 567, p. 65-76 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rift Valley fever virus 100%
  • Epitopes 54%
  • Viruses 42%
  • Proteins 23%
  • Arboviruses 21%
  1 Scopus citations

• RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine

  Jangra, S., Laghlali, G., Choi, A., Rathnasinghe, R., Chen, Y., Yildiz, S., Coughlan, L., García-Sastre, A., De Geest, B. G. & Schotsaert, M., 8 Nov 2022, In: Frontiers in Immunology. 13, 974016.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • poly(oxyethylene) cholesteryl ether 100%
  • Influenza Vaccines 97%
  • Inactivated Vaccines 90%
  • Vaccines 64%
  • Vaccination 58%

• Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multitarget approach

  Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., van de Guchte, A., Khan, Z., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., Alshammary, H., Fabre, S., Amoako, A., Obla, A., Alburquerque, B., Patiño, L. H., Ramírez, J. D., Sebra, R., Gitman, M. R., Nowak, M. D., & 6 othersCordon-Cardo, C., Schutzbank, T. E., Simon, V., van Bakel, H., Sordillo, E. M. & Paniz-Mondolfi, A. E., Apr 2022, In: Journal of Medical Virology. 94, 4, p. 1606-1616 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry 92%
  • Polymerase Chain Reaction 45%
  • Binding Sites 35%
  6 Scopus citations

• RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York City

  Mount Sinai PSP Study Group, Jul 2022, In: Journal of Molecular Diagnostics. 24, 7, p. 738-749 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry 92%
  • Polymerase Chain Reaction 45%
  • Binding Sites 44%
  2 Scopus citations

• Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

  the VRC 316 Study Team, Feb 2022, In: Nature Medicine. 28, 2, p. 383-391 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ferritin 100%
  • Influenza Vaccines 92%
  • Ferritins 84%
  • Nanoparticles 72%
  • Safety 69%
  30 Scopus citations

• Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

  Duc Dang, A., Dinh Vu, T., Hai Vu, H., Thanh Ta, V., Thi Van Pham, A., Thi Ngoc Dang, M., Van Le, B., Huu Duong, T., Van Nguyen, D., Lawpoolsri, S., Chinwangso, P., McLellan, J. S., Hsieh, C. L., Garcia-Sastre, A., Palese, P., Sun, W., Martinez, J. L., Gonzalez-Dominguez, I., Slamanig, S., Manuel Carreño, J., & 13 othersTcheou, J., Krammer, F., Raskin, A., Minh Vu, H., Cong Tran, T., Mai Nguyen, H., Mercer, L. D., Raghunandan, R., Lal, M., White, J. A., Hjorth, R., Innis, B. L. & Scharf, R., 9 Jun 2022, In: Vaccine. 40, 26, p. 3621-3632 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe acute respiratory syndrome coronavirus 100%
  • Newcastle disease virus 79%
  • adverse events 77%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 72%
  7 Scopus citations

• Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

  Pitisuttithum, P., Luvira, V., Lawpoolsri, S., Muangnoicharoen, S., Kamolratanakul, S., Sivakorn, C., Narakorn, P., Surichan, S., Prangpratanporn, S., Puksuriwong, S., Lamola, S., Mercer, L. D., Raghunandan, R., Sun, W., Liu, Y., Carreño, J. M., Scharf, R., Phumratanaprapin, W., Amanat, F., Gagnon, L., & 27 othersHsieh, C. L., Kaweepornpoj, R., Khan, S., Lal, M., McCroskery, S., McLellan, J., Mena, I., Meseck, M., Phonrat, B., Sabmee, Y., Singchareon, R., Slamanig, S., Suthepakul, N., Tcheou, J., Thantamnu, N., Theerasurakarn, S., Tran, S., Vilasmongkolchai, T., White, J. A., Bhardwaj, N., Garcia-Sastre, A., Palese, P., Krammer, F., Poopipatpol, K., Wirachwong, P., Hjorth, R. & Innis, B. L., Mar 2022, In: eClinicalMedicine. 45, 101323.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Newcastle disease virus 100%
  • 1018 oligonucleotide 98%
  • Severe Acute Respiratory Syndrome 94%
  • Coronavirus 92%
  • Vaccines 55%
  12 Scopus citations

• SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice

  Winkler, E. S., Chen, R. E., Alam, F., Yildiz, S., Case, J. B., Uccellini, M. B., Holtzman, M. J., Garcia-Sastre, A., Schotsaert, M. & Diamond, M. S., Jan 2022, In: Journal of Virology. 96, 1, e01511-21.

  Research output: Contribution to journal › Article › peer-review

  • Severe acute respiratory syndrome coronavirus 100%
  • angiotensin converting enzyme 2 86%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 72%
  • human diseases 62%
  29 Scopus citations